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Abstract
Total resection of glioblastoma multiform (GBM), the most com-
mon and aggressive malignant brain tumor, continues to be a chal-
lenge. Achieving complete resection is limited by difficulty in in-
traoperative discrimination between normal and residual tumor
cells. This project contributes to the development and evaluation
of a fiber-optical based fluorescence/reflectance spectroscopy sys-
tem as an intraoperative guiding tool, using δ-aminolevulinic acid
(ALA)-induced Protoporphyrin IX (PpIX). The main aim is to
combine the diagnostic potential of reflectance and fluorescence to
improve clinical applicability. In this context, 5 LEDs coupled to
a hand-held optical fiber was employed to deliver UV/visible light
to the sample sequentially. Remitted light from the tissue; includ-
ing diffuse reflected and fluorescence of endogenous and exogenous
fluorophores, as well as its photobleaching product, is transmitted
to one photodiode and four avalanche photodiodes. This instru-
ment has been evaluated with very promising results by performing
various tissue-equivalent phantom laboratory and clinical studies.
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POPULAR SCIENCE
A primary brain tumor is an abnormal growth of cells in brain
tissue. Brain tumors are classified as either benign (not invading
healthy tissue) or malignant (infiltrating and destroying healthy
tissue), depending on their degree of malignancy and aggressive-
ness. Benign brain tumors grow slowly and will not invade and de-
stroy surrounding tissue, but will grow as a solid encapsulated tu-
mor. Benign tumors thus have a clear border and can be removed.
Malignant brain tumors contain cancer cells, are usually rapidly
growing and life-threatening. These tumors intend to spread into
the nearby healthy brain tissue and may recur after treatment.
Glioblastoma multiform (GBM) is an example of highly malig-
nant brain tumors. The prognosis for patients with GBM is of
high concern, as it is associated with fast growth. Without ther-
apy, patients die within three months and with optimal therapy,
have a mean survival of approximately 12 months [1]. The main
challenge in the therapy of this tumor is associated with its infil-
trative growth and visual similarity of GBM to the surrounding
brain tissue so that complete resection under white light, even in
experienced hands, is between 13% and 20% [2].
Among all technologies and treatment algorithms employed in
the treatment of this tumor type, intraoperative fluorescent tumor
visualization has shown great promise. In this study, we aimed at
developing a combined fluorescence/reflectance spectroscopy sys-
tem that can assist the surgeon in distinguishing tissue types dur-
ing brain tumor resection. The contrast agent used to provide
the fluorescence contrast is δ-aminolevulinic acid (ALA)-induced
protoporphyrin IX (PpIX). The ALA is administered orally to the
patient prior to surgery. Malignant glial tumor tissue will then
build up a higher concentration of Protoporphyrin IX, providing a
fluorescence peak at 635 nm following 405 nm light excitation. The
primary goal is obviously to provide a signal with high sensitivity
and specificity for malignant tissue. Successful performance eval-
uation of this instrument has been demonstrated by performing
various tissue-equivalent phantom laboratory and clinical studies.
v

ACRONYMS and Abbreviations
ALA δ-aminolevulinic acid
PpIX Protoporphyrin IX
OTP Optical Touch Pointer
CNS Central Nervous System
GBM Glioblastoma Multiform
CT Computed Tomography
MRI Magnetic Resonance Imaging
FGR Fluorescence Guided Resection
iMRI Intraoperative Magnetic Resonance Imaging
BBB Blood-brain Barrier
IR Infrared
NIR Near-infrared
NADH Nicotinamide adenine dinucleotide
FAD Flavin adenine dinucleotide
PDT Photodynamic Therapy
PCA Principal Components Analysis
CA Correspondence Analysis
MDS Multidimensional Scaling
PLS Partial Least Square
PCR Principal Component Regression
MLVR Multiple Linear Regression Analysis
LOOCV Leave-one-out cross-validation
LED Light-emitting diode
DAQ Data acquisition
APD Avalanche photodiodes
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ACRONYMS and Abbreviations
PD Photodiode
FFT Fast Fourier Transfer
DCM 4-(dicyanomethylene)-2-methyl-6-(p-
dimethylaminostyryl)-4H-pyran
APD Avalanche photodiodes
PD Photodiode
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Chapter 1
Introduction
Surgical resection of glioblastoma tumors, the most common and
aggressive type of malignant brain tumor, is difficult due to its
similarity in appearance to surrounding brain tissue and its infil-
trative growth pattern. The standard method used today for tissue
discrimination during surgical resections is visual inspection and
palpation. Ultrasound and MR images are also taken before and
after surgery in order to locate the tumor, delineate the borders
between malignant and healthy tissue, as well as to verify the re-
sult of the resection. This information is not always sufficient for
optimal surgical results.
The main idea of this project is to develop a system that can
assist the surgeon in distinguishing tissue types during brain tu-
mor resection. This system is based on an optical fiber probe,
enabling in vivo fluorescence and reflectance spectroscopy during
surgery. The tissue discrimination in the fluorescence signals is
based on both endogenous fluorescence and contrast agents, while
the reflectance correlates with optical properties of the tissue. The
contrast agent employed is δ-aminolevulinic acid (ALA)-induced
protoporphyrin IX (PpIX). It is assumed that the PpIX concen-
tration is well correlated with the malignant transformation of the
tissue. The ALA is administered orally to the patient prior to
surgery. Malignant glial tumor tissue will then build up a higher
concentration of Protoporphyrin IX, providing a fluorescence peak
at 635 nm following 405 nm light excitation. The primary goal is
obviously to provide a signal with high sensitivity and specificity
for malignant tissue.
The idea for the system is thus to combine multi-wavelength
diffuse reflection and fluorescence signals to obtain information re-
lated to PpIX concentration, independent on the amount of blood
in the tissue. This would be an improvement to the the previ-
ous generation of this setup, called optical touch pointer (OTP)
[3], which was also somewhat sensitive to ambient light during the
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measurements, such as microscope lamp and room light in the op-
erating room. In that system laser was as a source for fluorescence
excitation illumination and a spectrometry method was used to de-
tect fluorescence signals during tumor resection. The suppression
capability of background light was not fully optimal, mainly due
to that the signal integration time was rather long. In this study,
by pulsing the light sources and employing lock-in type detection,
this ambient light can very efficiently be suppressed in the detec-
tion. This method has in lab tests proven to detect very low PpIX
fluorescence concentrations in tissue phantoms, with insignificant
influence of ambient light. An in vivo elaborate test on skin tu-
mor was conducted with this specific system to demonstrate its
full capability, before the systems will be taken into use in the on-
going clinical research program for glioblastoma tumors conducted
in collaboration with Linko¨ping University.
Chapter 2 contains a general description of the anatomy of hu-
man brain and brain tumors, concludes with a subsection focusing
on the surgical diagnosis and resection of brain tumors modalities.
Chapter 3 contains a general introduction to the concept of light
propagation through the biological tissue. Chapter 4 describes the
design of the instrument and the analysis methodology, as well as
the samples contents. The following chapters provide the results,
describing the experimental procedures using a phantom that mim-
ics the brain optical properties and the in vivo clinical trials. An
overview of the main findings of this study and evaluation of the
current state of project as well as future work of this project are
included in chapter 7.
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Figure 2.1. Anatomy of the
brain.(Image adapted from [4]).
Chapter 2
Brain
2.1 The Human Brain
The human central nervous system (CNS) is part of neural tissue
which is encapsulated within the skull and spinal cord and localized
in the brain and spinal cord. The brain, the most complex organ of
body, constitutes 2% of the body weight, while it consumes more
than 30% of its energy supply. The major region of the brain in-
cludes the cerebrum, cerebellum and brainstem, see Fig. 2.1. The
cerebrum contains the largest compartment of brain. It can be
divided in the left and right cerebral hemispheres, each composed
of outer gray matter (2 to 4mm) [6] and white matter (the bulk of
the brain), see Fig. 2.2. Gray matter is also called cerebral cortex
and comprises neurons, or nerve cell bodies and their dendrites as
well as glial cells. The inner white matter consists mostly of glial
cells and nerve fibers. The cerebrum is associated with several
body functions, some of which include thinking, perceiving, move-
ment, parts of speech, planning and organization. The cerebellum
can in a similar way be divided in left and right cerebellar hemi-
spheres and the vermis in between these two parts. The cerebellum
is involved in the regulation and coordination of muscle activity.
The brainstem, located between the cerebrum and the spinal cord,
comprises the midbrain, the pron and the medulla. This struc-
ture is responsible for various vital functions such as regulating
the respiratory and cardiac systems, as well as auditory and visual
reflexes, etc. [7].
The nervous system is built from billions of cells, mainly neu-
rons and glial cells [8]. Glial cells occupy half of the brain and
support and protect the neurons and also supply nutrients and
oxygen to the neurons. Nerve fibers, mainly located in the white
matter are involved in transmitting signals to and from the brain.
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Gray mater    
White mater  
Figure 2.2. Frontal section of
brain.(Image adapted from [5]).
2.2 Brain Tumors
A brain tumor is referred to as an unnecessary growing of cells
in the brain. There are two types of brain tumors, primary brain
tumors and metastatic brain tumors. The former includes any
tumor that originates and tends to stay in the brain, while the
latter is a malignant lesion originating in any part of the body
and is spread to the brain. Brain tumors are classified depending
on the region of the tumor, the type of tissue involved, whether
they are benign or malignant and also how they appear under the
microscope. Tumors are diagnosed, named and graded based on
their classification system. This grading and classification system
facilitates the planning of the treatment and the prediction of the
outcome [9]. The grade of tumor indicates its level of malignancy.
Grade I tumors, according to the WHO grading system, are the
least malignant and slow growing brain tumors. A grade
I tumor, which is often considered as benign, occurs more
frequently in children and is associated with long-term sur-
vival. It has a normal appearance under the microscope and
surgery is often a sufficient treatment for these tumors.
Grade II is more common between the age of 20-50. Such tu-
mors are relatively slow growing and the cells look slightly
abnormal in the microscope. Recurrence sometimes happens
even after complete surgical removal. Patients with such a
tumor need to be followed up after surgery to detect any
recurrence at an early stage, and may be considered for ad-
ditional treatment options.
Grade III indicates a high grade tumor. Such a tumor actively
reproduces abnormal cells. Such tumors tend to spread to
nearby normal tissue of the brain and often recur after treat-
ment as a higher grade of tumor.
Grade IV is a highly malignant brain tumor. A grade IV brain
tumor grows fast and forms new blood vessels, so as to main-
tain its rapid growth. Glioblastoma is the most common
example of this grade of tumor.
The most common type of brain tumor is glioma which arises
from glial cells and counting 30% of the brain malignancies [10].
Gliomas, as these tumors are called, have a variety of grades and
are divided to three main types: astrocytoma, oligodendroglioma,
and mixed oligoastrocytomas [11].
Astrocytoma tumors are the most common type of glioma and
can be divided into two categories: 1) protoplasmic astro-
cytes are typically found in gray matter and 2) fibrillary as-
trocytes (glioblastoma) usually located within white matter.
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Figure 2.3. MR image of GBM
Illustrates the spread of disease.
(A) Arrow points to the GBM
before surgery. (B) Scan after
gross total resection with surgery
following radiation therapy. (C)
Recurrence of disease 6 months
after surgery and not only in the
resection margin also in frontal
lobe. (D) Scan after resection of
both recurrent tumors. (E) 3
months later,illustrating the
tumor recurring at the resection
margin. Image is adapted from
[13].
These tumors range from low grade to highly malignant. A
low grade astrocytoma can be removed completely by surgery
and many patients live for long periods of time after diagno-
sis. It is believed that this type of tumor in adults has the
potential to recur, manifesting as higher grade tumors. The
highest graded astrocytoma is grade IV glioblastoma (grade
IV GBM) and accounts for approximately 50% of Astrocy-
tomas tumors.
Oligodendrogliomas develop from special glial cells called oligo-
dendrocyte and occur mostly in the frontal or temporal lobes
of the cerebrum. These type of tumors account for 4% of all
primary brain tumors and 12 to 20% of gliomas. They tend
to diffuse into the surrounding tissue, which makes them dif-
ficult to completely remove.
2.2.1 Glioblastoma
Glioblastoma multiform (GBM) is a grade IV astrocytoma, and
the most aggressive primary brain tumor in adults [9]. GBM can
be classified as primary and secondary. Primary GBM covers 60%
of the cases in adults over 50 years of age, while the secondary
accounts for the rest, has a slower growth pattern and occurs more
in younger patients. GBM is mostly found in the supratentorial
white matter of the cerebral hemispheres, and can invade into the
gray matter. It can, however, occur in any lobe of the brain. GBM,
as is understood from the name, has a variable histopathology. It
is composed of many heterogenous mixtures of cells and tends
to spread aggressively. The prognosis for patients with GBM is
not good, as it is associated with fast growth. Without therapy,
patients die within three months and with optimal therapy, have
a mean survival of approximately 12 months [1].
2.3 Present alternatives to the surgical
diagnosis and resection of brain tumors
Imaging studies are essential in order to locate and diagnose GBM.
A computed tomography (CT) scan is an efficient way to determine
the location and size of a tumor. This technique may, however, fail
in depicting all multifocal lesions. Magnetic resonance imaging
(MRI) has a higher confidence in revealing detailed information of
the brain and diagnoses 92% of all malignant gliomas [12]. Positron
emission tomography (PET) and magnetic resonance spectroscopy
(MRS) are also useful to detect recurring brain tumors. The com-
plex characteristics of brain tumors and their infiltrative growth
into the surrounding tissue make it difficult to locate all tumors,
and this is one of the reasons the tumors are resistant to conven-
tional therapies, see Fig.2.3.
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2.3 Present alternatives to the surgical diagnosis and resection of brain tumors
Figure 2.4. Kaplan-Meier overal
survival curves for GBM
diagnosed patient. (Image is
adapted from [13]).
The first treatment step is, in most cases, surgical resection of
as much of the tumor as possible. This initial treatment is almost
always followed by radiation therapy and chemotherapy. In gen-
eral, even after a successful tumor removal and with respect to all
treatment modalities, the median survival of this disease ranges
from 2-3 months to 1 year, see Fig. 2.4 [13]. Stummer et al. re-
ported a correlation between extent of resection and survival with
a survival advantage of 5 months [14]. This poor outcome has
drawn significant attention to using intraoperative modalities to
enable improved resection during surgery. The spatial shift in the
position of the brain due to change in intracranial pressure when
opening the skull during surgery decreases the usefulness of pre-
operative imaging. Several techniques, including CT, MRI, neu-
ronavigation, ultrasound, and fluorescence guided resection (FGR)
are the intraoperative modalities used today.
Intraoperative MRI and CT: CT provides a direct image of
the clinical situation of the patients. A CT navigation pro-
cedure takes place on a CT table in real time to assist the
neurosurgeon reach the deep lesion [15]. Intraoperative MRI
(iMRI) presents a better surgical outcome as a result of bet-
ter soft tissue contrast and higher resolution using high-field
iMRI. The high cost of this technology can, however, be an
obstacle.
Intraoperative ultrasound: This modality has an advantage
over MRI in being inexpensive and portable. Like MRI it
does not need to use ionizing radiation and can be used by
neurosurgeon without assistance. Intraoperative ultrasound
can have rather poor tissue contrast and is difficult to use
for deep lesions [16].
Fluorescence guided resection (FGR): This new technique
has recently been introduced to provide a direct optical iden-
tification of glioblastoma tissue. The technique usually em-
ploys a fluorescent contrast agent to label the malignant tis-
sue. This contrast agent is administered systemically prior
to the surgery. Usually δ-aminolevulinic acid (ALA)-induced
protoporphyrin IX (PpIX) is employed as a contrast agent.
Its selectivity is based on the fact that the blood-brain bar-
rier (BBB) is broken in tumor tissue and ALA is not able
to cross intact BBB [17]. Altered pattern of enzyme activity
[18, 19] and limited availability of iron level in tumor cells
[20] are also parameters contribute in ALA uptake in brain
tumors. Further reasons for selective accumulation of PpIX
within tumor cells is still subject to investigate. Thus far,
results indicate that FGR is feasible, promising, and it has
proven to be significant in delineating tumor margins. The
technique is partly limited insofar as that only superficial
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tissue can be visualized, and only when the ambient surgical
light is switched to violet light excitation.
Neuronavigation: Intraoperative neuronavigation is usually
used in combination with high-resolution pre-operative imag-
ing modalities. This combination of information provides the
surgeon with the ability to see the target point accurately in
the brain in three dimensions.
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Chapter 3
Biomedical Optics
When light interacts with matter in a sample, different processes
or phenomena can occur. They all lead to an alteration in the
light field and can transfer energy between the light to field and
the matter. This chapter outlines the different light tissue interac-
tion mechanisms, either as surface properties, such as reflection, or
volume effects such as scattering and absorption. Thereafter, fluo-
rescence and its capability in biomedical diagnostics are presented.
Tissue
Diffuse 
reflectance
Specular 
reflectance Incident light
Absorption
Scattering
Fluorescence 
emission
FluorophoreChromophore
Figure 3.1. Schematic presentation of the interaction between light and
tissue.
3.1 Reflection
When light impinges on a surface of a medium, it will partly be
reflected in and partly transmitted through the surface. This inter-
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actions is due to a difference in refractive index of the two media,
and is governed by the Fresnel reflection laws. The reflected light
has a mirrored propagation direction. This light is called specular
reflected light. The light transmitted through the surface will be
refracted according to the Snell’s law and the light direction is thus
slightly altered. Most of the light transmitted through the surface
of a biological sample into the medium will be scattered one or
multiple times in the medium (see Fig.3.1). Some of that scat-
tered light will escape the medium. This light is called diffusely
reflected light.
3.2 Absorption
When light is incident on tissue composed of different molecules, it
can be absorbed by various chromophores. Chromophores are de-
fined as molecules that can absorb visible light. Here we extend the
definition to include also molecules that can absorb near-infrared
light. The property of these molecules to absorb light is given by
the energy level structure of that molecule, having an excited en-
ergy level at a position matching the energy of the photon that
can be absorbed. This absorption phenomenon results in transfer-
ring the energy of a photon to the absorbing molecule, while the
molecule makes a transition from the ground energy state to an
excited energy state. This thus leads to a reduction in the inten-
sity of the light within the tissue. The intensity of a light beam in
an absorbing medium can be expressed by the Beer-Lambert law:
IT = I0 ∗ exp(−µad).
When µa is the probability of light absorption by tissue
molecules per unit path length, while d is the path length of the
light within the medium. The absorption of light is strongly de-
pendant to the wavelength, see Fig. 3.2. As can bee seen in the
figure, in the approximate wavelength region between 600-1300
nm, the total absorption is relatively low. This wavelength region
is called the tissue optical window, and is used for many diagnos-
tic and therapeutic purposes, since the tissue is more transparent
and this will provide possibility to reach deep targets in tissue
due to good light penetration. The most important absorbers in
biological tissues will be discussed in the following .
Water is the most abundant chemical compound of our body,
accounting for approximately 2/3 of total body mass. As
such, it can be considered a strong absorber in the tissue,
especially outside the visible region of the light spectrum.
The absorption coefficient of water is low within the tissue
optical window and has a first distinct absorption peak at 980
nm. Above this wavelength, the absorption starts to increase
10
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2
Tissue optical window
Figure 3.2. Absorption spectra of the main tissue chromophores. Image
is adapted from [21].
fairly rapidly in the infrared (IR) region and continues to
increase at longer wavelength into the mid-infrared.
Haemoglobin is an iron-containing protein in the blood with
the function to carry oxygen from the lungs to the tissue.
Both oxyhemoglobin and deoxyhemoglobin are dominant ab-
sorbers of light in the visible wavelength region. Differences
in spectral in absorption features of these two forms can be
utilized to measure changes in hemoglobin saturation and
tissue oxygenation.
Melanin is a dark pigment, giving the hair, skin, and the iris
its natural colors, and has an absorption peak around 335
nm. The absorption then decreases slowly with wavelength
throughout the entire visible spectral region. Melanin can
also be found in other organs, e.g. inside of eye [22] and in
brain [23].
Lipids have less significant contribution in the visible wavelength
spectrum. Similar to the water, in the Near-infrared (NIR)
region the absorption cannot be neglected.
3.3 Scattering
Scattering of light in turbid media occurs due to mismatches be-
tween refractive indices of different small structures in the medium.
In tissue different cellular structures, mainly mitochondria and nu-
clei [24] exhibit different refractive indices and give rise to light
scattering, changing its direction. The interested reader is referred
to Popp et al. [25] for detailed information about the microscopic
origin of light scattering in tissue. Two tissue parameters can
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be used to describe this phenomena, the scattering coefficient µs
and the anisotropy factor g. The scattering coefficient defines the
fraction of light scattered per unit of length, while the anisotropy
factor g =< cosθ >, where θ is the scattering angle, determines the
degree of forward scattering in each individual scattering event. If
the scattering is isotropic, g is equal to zero. The g-value depends
on the size and refractive index of the scattering structures, and
it tends to become close to unity when the size of the scattering
structures becomes large in comparison to the wavelength of the
light. The case of highly scattering tissue, when light becomes
diffuse from multiple scattering events, a reduced scattering coef-
ficient µs can be derived by combing this two quantities.
µ′s = (1 − g)µs
The scattering in tissue is typically dominated by Mie scatter-
ing, since the size of the particles is larger than the light wave-
length. The wavelength dependance for Mie scattering can be
expressed by the following expression:
µ′s = aM .λ
−b,
where the coefficient b > 0 is related to the particle size and aM is
scattering amplitude linked to the density of scatterer particles in
the tissue. As the particle size decreases to become smaller than
the light wavelength, Rayleigh scattering dominates. For this the
wavelength dependence is:
µ′s ∝ λ−4.
Based on these two scattering effects, there is a more general ex-
pression for tissue scattering,
µ′s = aλ
−b.
3.4 Fluorescence
Transitions between energy states of atoms and molecules fre-
quently occur by photon processes such as absorption and emis-
sion. Once a fluorescent molecule is excited due to the absorption
of light, a number of things can occur. One possibility is that the
molecule returns to the ground state from the lowest vibrational
level of an excited singlet state and emits light with longer wave-
length, lower photon energy as compared to the excitation light
that is, fluorescence, see Fig. 3.3. Fluorescent molecules are called
fluorophores or fluorochromes. The spectral difference between the
excitation and emission wavelength is called the Stokes shift. The
molecule-specific Stokes shift is a key property that allows fluores-
cent molecules to be identified and utilized for tissue diagnostics.
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Figure 3.3. Jablonski diagram of
fluorescence event.
This is particularly important in multiplex fluorescence applica-
tion, because the emitted light from one fluorophore may excite
another one within the sample.
Fluorescence is a short-lived luminescence event, with a fluo-
rescence lifetime in the order of ns. Each fluorophore has a char-
acteristic absorption and emission spectrum. The excitation can
occur at several wavelengths, with one wavelength yielding the
highest fluorescence emission. This is, not surprisingly, called the
excitation peak. Similarly, the wavelength of the strongest emis-
sion is called emission peak. An intrinsic property of fluorophore
is the fluorescence quantum yield (Φ). It is a probability type of
function defined as the ratio of the number of fluorescence photons
emitted to the number of excitation photons absorbed. Another
important property of the fluorophore is whether it is prone to
photobleaching. During a prolonged exposure or a high intensity
excitation light, the fluorescence quantum yield may decrease -
photobleaching. Photobleaching is an irreversible photochemical
destruction of the fluorophore. The molar extinction coefficient ()
is yet another intrinsic property of a fluorophore, defined as the
probability for light absorption per unit path-length of light at a
given wavelength for one molar concentration of the fluorophore.
The product of the two quantities, fluorescence quantum yield (Φ)
and extinction coefficient (), represents the brightness of a fluo-
rophore.
3.4.1 Autofluorescence
The autofluorescence, or endogenous tissue fluorescence, is defined
as fluorescence emission of unstained biological structure under
UV or visible light irradiation. The emission spectra of this en-
dogenous fluorescence is broad with overlapping contributions from
several fluorophores, making it difficult to separate contribution of
different fluorophore. The fluorescence emission spectra of most
abundant natural fluorophores can bee seen in Fig. 3.4.
NADH (nicotinamide adenine dinucleotide) and FAD (flavin ade-
nine dinucleotide) are two coenzymes involved in several im-
portant reactions in the cell metabolism. The fluorescence
properties of the reduced form of NADH differ from that of
the non-reduced form NAD+, and is thus an indicator of
the metabolic state of the tissue. By detecting the level of
NADH by means of its fluorescence emission, one can get
information valuable in the diagnostics of malignant disease.
Similar information can be obtained from the fluorescence of
the flavin.
Collagen and elastin are the most important structural protein
maintaining the firmness and elasticity of tissue, respectively.
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Figure 3.4. a) Absorption and b) emission spectra of some tissue
fluorophores. The graph is adapted from [26].
The fluorescence emission of collagen and elastin is associ-
ated with connective tissue and can be used to differenti-
ate between various tissue types and to characterize tissue
pathologies [27].
Tryptophan is an amino acid present in all cells and the most
common tissue fluorophore in tissue.
Porphyrin are molecules in the body that combine iron to pro-
duce heme. The porphyrin fluorescence emission is in the
red spectral range.
Table 3.1: Main endogenous fluorophores in tissue [28]
Fluorophore Excitation maxima (nm) Emission maxima (nm)
NADH [29] 290, 320-360 440-460
Collagen 325, 360 395-405
Elastin 290, 325 340-400
FAD [30] 365, 450 535
tryptophan 280 350
Porphyrin 400-450 630-690
Tissue autofluorescence can be used to distinguish different
types and states of tissue and as a criterion for tissue diagnostics.
Table 3.1 gives the excitation and emission wavelength for the
most important tissue fluorophores.
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3.4.2 Fluorescent tumor markers
In order to enhance the sensitivity and specificity of fluorescence
tumor diagnostics, fluorescent tumor markers are frequently em-
ployed as exogenous fluorophores. An important characteristic of
these tumor-seeking markers are their selective accumulation in the
malignant or pre-malignant tissue following drug administration -
topically or systemically (the latter through injection or orally).
A suitable tumor marker needs to have a higher selectivity for
malignant tissue and a rapid accumulation after administration.
Another property of a fluorescent tumor marker is an intense and
specific fluorescence emission following light excitation. A high flu-
orescence yield with narrow emission spectrum, preferably in the
red region, makes it possible to easily be distinguished from the
tissue autofluorescence, and also helps to improve diagnostics of a
malignancy. In some cases the same substance can also be used
as a photosensitizer for treatment of the malignant tumor utiliz-
ing photodynamic therapy (PDT). In PDT, the photosensitizer
molecules absorb the specific treatment light, whereupon reactive
oxygen species are produced, killing nearby cells.
Glycine
    +
Succinyl CoA
5-aminolevulinic acid(ALA)
Porphobilinogen
Uroporphyrinogen III
Coproporphyrinogen III
protoporphyrinogen IX
Protoporphyrin IX(PpIX)
Haem
Hydroxymethylbilane
ALAS
Mitochondrion
cytosol
Figure 3.5. Eight steps in the heme biosynthesis pathway.
Among all fluorescent tumor markers, 5-aminoleuvulinic acid
(ALA) induced-protoporphyrin IX (PpIX) is most widely used.
ALA is an endogenous amino acid essential for the heme biosynthe-
sis pathway, see Fig. 3.5. Heme biosynthesis begins by producing
ALA in the mitochondrion, while the final product is formed by
insertion of a ferrous ion in PpIX by the help of the ferrochetalase
(FC) enzyme. When an excessive amount of ALA is administered
to the system, FC isn’t able to directly convert all produced PpIX
to heme, which results in a temporary accumulation of PpIX in
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Figure 3.6. Absorption and
emission spectra of PpIX.
the cells [31]. The selectively higher accumulation of PpIX in ma-
lignant cells can be explained by the disrupted BBB, differences
in activity of enzymes contributed in heme biosynthesis and lower
availability of iron in tumor cells. Many studies are performed in
order better to understand this process [17–20].
The tumor concentration of PpIX reaches its maximum within
1-6 hours, depending on tumor type, after oral intake or intra-
venous injection of ALA. Fig. 3.6 shows the absorption and emis-
sion spectra of PpIX.
An important clinical study using ALA for guiding brain tu-
mor resection was presented by Stummer et al. [32–34]. Proto-
porphyrin IX was induced by administering a dose of 20 mg/kg
body weight ALA prior to intraoperative fluorescence microscopy
guidance during surgery. The outcome of this work was a specific
improvement of gross total resection in high grade glioma surgery.
3.4.3 Multivariate analysis of fluorescence data
Multivariate analysis are widely used to evaluate data sets with
large and complex amount of information with more than one vari-
ables. Depending on the data set and the information requested,
different multivariate analysis methods can be employed. If the
collected data set comprises several measurements, principal com-
ponents analysis (PCA), correspondence analysis (CA), and multi-
dimensional scaling (MDS) can be used. Among these techniques,
PCA is the oldest and most popular method. The goal of PCA is
to decompose the data set by reducing the number of dimension,
while minimizing any loss of information.
In the case of more than one data set, when one set contains
independent variables (or predictors) and the second data set cor-
responds to dependent variables (or responses), partial least square
(PLS), principal component regression (PCR), and multiple linear
regression analysis (MLVR) are the most frequently used meth-
ods for tissue fluorescence spectroscopy. PLS is useful when a
set of dependent variables needs to be predicted from a large set
of independent variables. In fact, PLS extract a linear combina-
tion of the predictors with the best correlation with responses but
doesn’t provide any information about underlying relationship be-
tween variables. PLS is believed to be the more optimal method for
concentration prediction [35]. When the number of predictor vari-
ables are more than responses, the data will be over-fitted which
leads to a poor prediction of the property of interest (e.g. concen-
tration in this thesis work). Validation methods enables to avoid
over-fitting by dividing the data set into two parts, training set
used to create a fitting model and validating set used to evaluate
the prediction test response. One of the most common forms of
cross validation is Leave-one-out cross-validation (LOOCV), where
only one single observation is used as the validation set and the
16
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remaining are used as the training set. An average square error is
computed to evaluate the model.
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Chapter 4
Experimental setup
This work implements a novel approach to fluorescence guided re-
section of the most malignant brain tumor, GBM. This chapter
reports on development of system design, its technical specifica-
tion, the light modulation and methods for processing signals, and
samples description used in this study.
4.1 System specifications
LEDs
Electronic Board
DAQ PC
Sample
Beam splitter
Bandpass filter
Longpass filter
Lens
Analog output Analog inputs
APD APD  PD
A
PD
APD
365   405    530   635 
FB405-10 FB470-10 FB530-10 FB635-10
Figure 4.1. Schematic representation of the system.
The system developed with the purpose to be useful for guid-
ing brain tumor resections is outlined in Fig 4.1, including a
schematic illustration of the distal end of the fiber-optic probe.
It has three main parts: A light source, a fiber optical probe and
a detector unit. The light source (Prizmatix Ltd.) consists of five
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light-emitting diodes (LED) at four different wavelengths: 365nm,
405nm, 530nm, 635nm as well as a white light LED. The UV light
(365 nm) is used to excite endogenous fluorophores in tissue, while
the violet light (405 nm) serves as an excitation source for PpIX.
The other wavelengths and the white light are used to provide re-
flection data and thus signals correlating with optical properties
from the tissue at these wavelengths. The maximal output power
of each LED is approximately 10 mW. The intensity of the light
is adjustable to avoid saturation on the photo detectors (and also
minimize photobleaching).
The light source is controlled by the output ports of a 16-bit
data acquisition (DAQ) board (Supplier, Type No. USB6351). A
labview program controls the light generation sequences and time
intervals between the on (high voltage) and off (low voltage) mode
of the LEDs. For this purpose, a custom made electrical board
was designed and connected to the Digital Clock (CTR) output
channel of the DAQ board.
The hand-held fiber-optical probe delivers light to the sample
by five optical fibers each with a core diameter of 750 µm, a nu-
merical aperture of 0.5 and a length of 4 meters suitable for the
operating room. The optical fiber located in the center of probe
is used to collect fluorescence and diffusely reflected light from the
sample and guides the collected light to the detection unit. There
is a fiber collimator (Edmund Optics; 64770) in front of the de-
tection unit. The collimated light is split into five different light
paths by means of four dichroic beam splitters (BS) (Thorlabs;
DMPL425, 505, 567, and 638, respectively). The detector after
the first beam splitter is a silicon photodiode (PD) (Edmund Op-
tics; 53378). This is employed to detect diffusely reflected UV and
violet light from the probed tissue. Four avalanche photodiodes
(APD) (Hamamatsu; S9075), are used to detect the collected en-
dogenous fluorescence light, exogenous PpIX-fluorescence and its
photobleaching products, and also reflectance from the red, green
and white LED. To suppress the strong diffusely reflected UV and
violet light from reaching the APDs, a long pass cutoff filter (3
mm Schott GG-435) is mounted after the first elastic channel.
Bandpass filters (Edmund Optics; FB405-10, FB470-10, FB530-
10, FB-635-10, and FB-660-10, respectively) are mounted in front
of each detector to transmit only the desired spectral band of light
to each detector. The bandpass filters are followed by a lens to
focus the light onto the center of the active area of the detectors.
The photocurrents from the photodetectors are first converted to
voltages by five trans impedance amplifiers, one for each detector,
transmitted to five analogue inputs of the DAQ board and then
sent to the computer. Real-time control and initial data analysis
is performed in LabView (Version 2012, National Instruments).
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Figure 4.2. a) TTL Pulse applied
on one LED. b) The sinusoidal
wave applied on one LED. c) FFT
spectrum from the detected
fluorescence and reflectance light.
4.2 Signal processing
Light intensity modulation has been employed in the data acquisi-
tion for two reasons. Firstly, it was important to measure the sig-
nals generated for the five LEDs independently. Secondly it was
essential to enable measurements in strong ambient light condi-
tions. Two different periodic waveforms: square-wave modulation
and sinusoidal-wave modulation, have been evaluated to modulate
the light from the source in this system. The square wave modu-
lation is based on a TTL signal generated from the CTR port of
the DAQ board, (see Fig. 4.2.a). A series of square wave pulses is
created with a varied voltage sequence with square wave voltage
pulses between 0 (low) and 5V (high) at a frequency of 777 Hz. The
resulting waveform from the square wave modulation consists of a
777 Hz repeated time sequence of 11 time slots. This sequence in-
cludes one time slot where each of the LEDs is on at maximum and
reduced power, respectively, and one where they are all switched
off. The main reason to apply voltage in high and low power is to
monitoring the power fluctuation resulted from temperature varia-
tion of LEDs. For each detection channel, the average signal value
within each of these time slots is calculated and then subtracted
from the average value when all LEDs are switched off. In order
to increase the signal-to-noise ratio, this sequence is repeated over
70 cycles and an average value was calculated, corresponding to a
90 ms integration time.
In sinus modulation, only the bue LED was used. The light was
driven by a sinusoidal wave at 777 Hz with a modulation ampli-
tude of 2.5V. Such a modulation wave is illustrated in Fig. 4.2.b).
The fast fourier transfer (FFT) of the recorded signal is used to
distinguish the frequency components of the detected signal. The
FFT spectrum is integrated over a frequency interval covering the
peak at 777Hz and also any signal contribution from the ambient
light is measured as a sum of all signals in the frequency interval
0-110 Hz, again averaged over 90 ms integration time. A typical
example of the FTT spectrum of a sinus wave is illustrated in Fig.
4.2.c).
4.3 Samples
In order to validate and test the system performance, water-based
tissue phantoms were prepared. The tissue phantom employed
in this study was based on three major ingredients, an absorber,
a scatterer and a fluorophore. Diluted Intralipid (Fresenius Kabi,
Sweden; 200 mg/ml), which is a fat emulsion, was added to provide
the required scattering properties, while diluted India ink (Pelican
Fount, Germany; 1:100 stock solution prepared in our lab) with
a minimal influence on phantom scattering and high contribution
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Figure 4.3. . Absorption and
emission spectra of DCM. Image
adapted from [36].
to the absorbtion, or bovine blood (purchased from a local super-
market), was used as absorbers. The DCM or PpIX (Fisher Scien-
tific) with similar fluorophore brightness and fluorescence emission
spectra properties was served as a fluorophore. DCM, which is a
strongly fluorescence dye with a very broad absorption spectrum,
can be excited using light at 470 nm. The excitation and emis-
sion spectra of DCM are presented in Fig. 4.3. In order better to
control and suppress any aggregation of PpIX in the phantom, the
surfactant tween (Scharlau Chemie) was mixed into the phantom.
The phantoms were designed to mimic the optical properties of
gray matter of brain tissue (See table 4.1).
Table 4.1: Tissue phantom substances composition by volume per-
centage
Substance Water (%) Intralipid (%) Ink (1:100 stock solution)
or Blood (%)
Volume 96 3.5 0.5
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Chapter 5
Experimental system validation
The developed system was designed to quantify the fluorescence
signals during glioblastoma resection surgery using ALA-induced
PpIX as the tumor marker. A set of tissue phantoms were prepared
to study the sensitivity and linearity of the system as well as the
ability to suppress ambient room light in the detection. The tissue
phantoms used in this study are described in chapter 4.
5.1 System linearity assessment
Several sets of experiments were carried out to validate our setup.
First only 405nm excitation light was used for studies on system
validation of linearity response in a dark room as well as under
well controlled ambient light conditions. This wavelength matches
the absorption thus is able to excite PpIX. The 405nm excita-
tion light also overlaps with the absorption of DCM, enabling this
light source to induce DCM fluorescence. Two amplitude methods,
sinusoidal and square wave modulation, were employed for their
ability to suppress any ambient light in the laboratory room. In
the first series of experiments liquid phantoms were prepared by
mixing 3.5% volume of Intralipid, 0.5% of Ink (1:100 stock solu-
tion) and 96% water. The fluorescence features of the phantoms
were manipulated using DCM as a fluorophore. In order to obtain
a 100 µM DCM solution, 0.015 g DCM (the molar weight is 303.37
g/mol) was dissolved in 0.5 L water and solubilized in ultrasonic
bath. The phantom with the highest fluorophore concentration
was prepared in a glass cylinder container. The lower concentra-
tions have subsequently been prepared by diluting with the initial
tissue phantom, without any fluorophore. Similarly, fluorophore
concentrations ranging between 25 and 1000 nM were prepared.
A gentle stirring of the sample during measurement was employed
to prevent the fluorophores from aggregation and to minimize the
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photobleaching so that the bleached dye molecules directly under
the tip of the delivering fiber were continuously replaced by fresh
fluorophores. Whereas these initial results were promising, new
samples containing PpIX instead of DCM as a fluorophore were
prepared to investigate the lower detection limit of PpIX flores-
cence. PpIX powder (0.056 g) was dissolved in 20 mL of DMSO
and 80 mL of distilled water was added to obtain a 1 mM PpIX
stock solution. The fluorophore concentration in the tissue phan-
tom was, in this series of measurements, varied in the same way
as before between 10 to 100 nM. Bovine blood (3% in volume)
instead of ink was used as absorbers to have a realistic wavelength
dependence in comparison to human tissue.
5.1.1 Result of linearity tests
The measured data need to be corrected to account for any small
variation in source power. For this purpose, the ratio between
fluorescence and reflection signals was formed. Figure 5.1 shows
the results from the first set of measurements. The ratio has a
very linear dependence on the fluorophore concentration for both
the square and sine wave modulations using 405 nm LED as an
excitation source.
There was a negligible difference in sinusoidal and square wave
modulation in this course of the experiment. The work has shown
that very low fluorescence concentration is detectable by this sys-
tem, much lower concentrations than is expected in brain tissue
during clinical use [37].
5.2 Ambient light suppression
As mentioned in the Introduction, the previous generation of this
setup (OTP) [3] was sensitive to the ambient light during the mea-
surements, such as fluorescence microscope lamp and room light in
the operating room. In order to evaluate the capability of suppress-
ing ambient light with the present system, measurements were con-
ducted with tissue phantoms under well controlled ambient light
conditions. In this study we used a white light ring-lamp from a mi-
croscope with similar emission spectrum to the surgical operating
microscope, to examine the influence of different light conditions
on the recorded signals. A tissue phantom (Similar composition to
4.1) with 100 nM PpIX concentration was prepared and the ring
light was located at varying distances vertically above the sample
to provide an even illumination of different intensities. A light-
meter was used to quantitatively determine the ring light intensity
at the surface of the tissue phantom. The experiment started with
a 60 centimeter distance from the sample. The distance was then
decreased to obtain a stronger ambient light condition. Both types
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R = 0.9996
R = 0.9990
2
2
Figure 5.1. PpIX quantification using violet light from two modulation
techniques. The solid line indicates a linear fit to the data.
of modulations were applied to investigate the capability of ambi-
ent light suppression.
5.2.1 Result
Figure 5.2 illustrates the results, including raw data, for different
ambient light conditions. Since the ambient light has the modu-
lations in the low frequency range (0-100 Hz), the detected sig-
nal with a modulation at 777 Hz is totally related to the light
from the LED source. In square modulation the low frequency
wavy shape of the raw data curves is related to the ring light
while the relatively small pulses were produced from the 777 Hz
frequency-modulated LED. Figure 5.2.b) illustrates the evaluated
signal level as a function of the ambient light intensity. In figure
5.2.c), the on-off lock-in type of subtraction was performed for the
777 Hz modulation to remove the influence of the ambient light.
As mentioned in the experimental setup chapter, the average sig-
nal value was for these plots calculated over 70 cycles to increase
the signal-to-noise ratio. The results clearly indicate that the mea-
sured signal is almost completely dominated by the ambient light,
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5.3 Evaluation protocol
while the fluorescence signal could be recovered almost uninflu-
enced by the ambient light when the lock-in type of subtraction
was performed. Comparing the results of this experiment and pre-
vious experiment, no remarkable difference was observed between
two modulation schemes so that the square modulation has been
picked to process signals afterwards.
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Figure 5.2. Sensitivity of the system to the ambient light level for
a fixed PpIX concentration of 100 nM. Figures (a) and (c) show the
raw data when the violet light was modulated by a square and sinu-
soidal waves, respectively. (b) and (d) demonstrate the fluorescence vs
reflection ratio (i.e. the evaluated signal corresponding to the PpIX
concentration) in different ambient light conditions for the two modula-
tion schemes. (e) presents the FFT spectrum of sinusoidal modulation
with peaks related to ambient light (below 100 Hz) and light from the
excitation source (777 Hz).
5.3 Evaluation protocol
Now, after having been able to successfully demonstrate the capa-
bility of suppressing any influence of ambient light on the detected
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signal using one 405 nm excitation source, all channels were con-
nected. The multiple LEDs were run sequentially using an elec-
trical board (multiplexer) connected to the DAQ board. In order
to evaluate the experimental data, multivariate analysis is used
in the data processing. The partial least squares (PLS) method
was employed to develop a linear model of sample fluorescence and
optical properties from 269 different samples varied in known de-
pendent variables such as absorption, scattering and fluorescence.
Intralipid concentration varies between 3% -8% of the whole phan-
tom volume, while 0%-4% of the blood concentration was consid-
ered as an absorption variation. Protoporphyrin concentration was
varied between 0 to 1000 nM. The samples were prepared through
several dilution steps starting from the highest concentration. It
was diluted into the lowest concentration and the last sample was
measured in a separate container without any fluorophore. The
measurement process occurs similarly to the previous experiment.
For the PLS model regression, data normalization was done and a
data matrix was created. This model can be used to predict the
fluorescence concentration in unknown samples in the future, as
long as the absorption, scattering and fluorescence properties fall
into the interval of this set of samples. Leave-one-out methodol-
ogy was used to evaluate the accuracy of predicting the fluorophore
concentrations. LOO-CV split the dataset into two groups, it left
one observation as the validation data, and the remaining obser-
vations were used to build the PLS regression model and this was
repeated so that each variable was used as validation data.
5.3.1 Result
Figure 5.3. PpIX quantification in liquid phantom with various optical
properties. a) Predicted Intralipid concentration b) Predicted blood
concentration and c) Predicted PpIX concentration.
Linear regression analysis was performed using the data from
all sample measures to correlate between predicted and true prop-
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erties for different variables. Figure 5.3 illustrates the relation
between these values and also indicates their coefficient of deter-
mination (R2). This coefficient denotes the goodness of linear re-
lation between responds and predicted values. As can be seen, the
estimated blood and intralipid concentration are highly correlated
with correlation coefficient of 0.96 and 0.96, respectively. For fluo-
rescence concentration, the correlation coefficient is 0.95. The re-
sult shows the viability of PLS regression for intralipid/scattering,
blood/absorption, and PpIX fluorescence concentration estimation
using the multi-LEDs arrangement. It was recognized that there
was an instability in the APDs temperature since it is well known
that APD gain is very sensitive to ambient temperature.
5.3.2 Temperature compensation
The APD’s high sensitivity and wide bandwidth makes it widely
used as a detector for optical measurements. The temperature de-
pendence of APD is a disadvantage and needs to be compensated
to achieve a stable output. The first attempt to overcome this is-
sue was to prepare a solid phantom as a reference. This reference
was measured before and after each experiment. The obtained
data can be normalized through dividing by this value. A tem-
perature calibration was also performed to get improved outcome
by monitoring the temperature variation and deriving the temper-
ature coefficient. In this study, thermistor coupled to each APD
allowed accurate monitoring of temperature during the measure-
ment. The temperature coefficient can be found and applied to
output voltages to correct the temperature dependence.
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Chapter 6
In vivo experiments
In order to ensure that the system will work in complex living
systems, an in vivo clinical human trial was performed. Skin tu-
mors are easily accessible and such tumors were used in this first
clinical trial. The whole setup was packed on to a portable case
for outpatient clinical data acquisition and carried to the clinic of
Dermatology at Sk˚ane University Hospital in Lund.
6.1 Materials and Methods
The fluorescence and reflectance spectroscopy system has previ-
ously been described in chapter 4 and 5. The measurement was
carried out on 22 patients with skin tumors. Among patients with
different types of skin tumors, eight were treated by photodynamic
therapy (PDT). These patients received a topical dose of ALA
(Amelux 78 mg/g and Metvix 160mg/g) in the cream 3 hours
before PDT. To investigate the effect of ALA on tumors, three
different cases were considered. In the first case the measurement
was performed prior ALA administration. In the second case the
data was captured before the treatment and in the last case it
occurred after PDT. To allow intersubject data analysis, optical
fiber was placed at four points outside of the lesion, two on the
border and rest inside of the lesion. This protocol could, however,
not be fully followed for all patients due to the limited size of the
tumor. For patients without PDT, the measurements were carried
out in order to investigate the tissue autofluorescence and diffuse
reflectance variation within the tumor and healthy tissue. The ex-
citation light used for autofluorescence is UV light and the data is
normalized to the reflection (405 nm detection channel) so as to
compensate the variation of light source intensity. At the 365 nm
excitation wavelength, most of autofluorescence arises from NADH
and flavin coenzymes which have emission at 420-470 nm [30]. Be-
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6.2 Result
   b)
   a)
Figure 6.1. A typical skin tumor
Figure 6.4. A malignant
melanoma on the upper back.
fore and after each measurement, the signal from a stable reference
was also acquired, to allow a compensation for any temperature or
other drifts in the system.
6.2 Result
Figure 6.2 presents one of the eight measurements (see Fig. 6.4) of
the different experiments conducted on patients with skin tumor
undergoing PDT. The PpIX accumulation at the site of application
in the skin tumor is obvious from the results presented in the
figure 6.2. In this case it was straight forward to detect the lesion
in the turbid tissue with a robust distinction. The curve after
PDT evidences PpIX existence after treatment which indicates a
somewhat prolonged photosensitivity of this drug in the lesion.
Fluorescence Vs. reϐlection
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Figure 6.2. In vivo fluorescence reflectance spectroscopy of a patient
with a skin tumor before ALA administration, before PDT and after
PDT.
The result of autofluorescence emission from endogenous fluo-
rophore of one patient, among 14 patients were not treated with
the PDT, is demonstrated in FIG 6.3. This tumor is diagnosed
as a malignant melanoma (See in Fig. 6.4). It shows the system
ability to distinguish between normal and tumors tissue by only
using the tissue autofluorescence.
In summary, significant differences have been noted between
optical properties of different types of tissue. This is the wealth of
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Figure 6.3. In vivo autofluorescence reflectance spectroscopy of patient
with malignant melanoma skin tumor.
this study that supports the use of both endogenous and exogenous
fluorescence in the biomedical optical applications. A further eval-
uation on complete data is proceeding to evaluate the diagnostic
potential of this spectroscopic system in classifying different skin
lesions.
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Chapter 7
Discussion and outlook
A novel combined fluorescence reflectance spectroscopy system
based on LED-excitation and APD-detection has been developed
and evaluated. The system is built as an intraoperative guiding
tool for resection of glioblastoma, the most frequent and complex
to treat the malignant brain tumor. The LEDs as diagnostic light
sources are interesting in respect of their compactness and low cost.
As well, it provides sufficient intensity at the desired wavelengths,
and any wavelength desired for the diagnostics. The main advan-
tage for the present application of APDs as detectors, instead of
a spectrometer used in the previous generation of the system [3],
is the short integration time. This makes it possible to correctly
subtract any ambient background light in a noise-free manner.
The combined use of reflectance and fluorescence, using differ-
ent wavelength of interest, optimizes the diagnostic capabilities.
The UV light excitation source provides information about tissue
autofluorescence properties. The other light sources are employed
to compensate for any variations of optical properties of the exam-
ined tissue. The use of multiple detection wavelengths in parallel
allows to also compensate for any small fluctuations in the LED
output by forming dimensionless ratios of detection signals. The
violet light is also utilized to induce PpIX fluorophore. Accurate
extraction of intrinsic fluorescence could potentially provide better
diagnostic accuracy.
The linearity study conducted demonstrates that very low flu-
orescence signal can be detected in the presence of strong ambient
light with the developed system. The ambient light suppression,
as a main challenge in previous study, is successfully achieved for
improved clinical applicability. Multivariate analysis of the signals
has proved a great potential in separating the contributions to the
signal from fluorescence, absorption and scattering in a serious of
tissue phantom measurements.
The temperature dependency of the internal gain of APDs is
33
an inherent feature of the APD, is considered as a main source of
error. Calibration for the temperature variation has been accom-
plished by mounting thermistor on each APD in order to moni-
toring the temperature variation on APDs, and deriving appropri-
ate correction coefficient. This work is still in progress, however
it has shown promise in increasing the correlations of the evalu-
ated signal with the PpIX concentration. Future progress in this
area will be performed before the next clinical study is conducted.
Additional reference measurement before and after each clinical
measurement has performed to utilize as a further calibration fac-
tor related to other sensitivity variations in the signal. This will
be continued also in the future clinical measurements, while the
variations corrected for by these extra measurements are expected
to be minuscule.
The clinical trials on skin tumors were performed in order
to test the instrument and its performance. While the data are
promising, future work will focus on improving the system perfor-
mance and preparing the setup to carry out real-time measurement
in collaboration with Linko¨ping University for ALA-guided brain
tumor resections.
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